Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,664
datasets available to search
ShareScore release 0.9.0
Dataset results
1,664 results for “plaque”
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03469336. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
ClinicalTrials.gov study NCT03774875. IPD Sharing: YES. Countries: 6. Publications: 2.
Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01777191. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
ClinicalTrials.gov study NCT03123471. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
ClinicalTrials.gov study NCT02203032. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Effect of Evolocumab on Coronary Plaque Characteristics
ClinicalTrials.gov study NCT04710368. IPD Sharing: NO. Countries: 1. Publications: 5.
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
ClinicalTrials.gov study NCT04053387. IPD Sharing: NO. Countries: 2. Publications: 2.
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01276639. IPD Sharing: Not stated. Countries: 11. Publications: 5.
Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01970488. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06011733. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05020249. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis
ClinicalTrials.gov study NCT04673786. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00329303. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
ClinicalTrials.gov study NCT04603027. IPD Sharing: NO. Countries: 4. Publications: 1.
A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)
ClinicalTrials.gov study NCT02423122. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
ClinicalTrials.gov study NCT01690299. IPD Sharing: YES. Countries: 11. Publications: 3.
An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
ClinicalTrials.gov study NCT02326298. IPD Sharing: Not stated. Countries: 5. Publications: 4.
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
ClinicalTrials.gov study NCT01212900. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
ClinicalTrials.gov study NCT02207244. IPD Sharing: Not stated. Countries: 9. Publications: 10.
A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
ClinicalTrials.gov study NCT02518048. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.